Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Mark C. Walters, MD
Healthcare Provider Program Director, Blood & Marrow Transplantation (BMT)
UCSF Benioff Children’s Hospital
Main Hospital
747 52nd Street
Oakland, California, United States
Dr. Walters is the director of Bone Marrow Transplantation at UCSF Benioff Children’s Hospital Oakland. He has been the Director of Stem Cell Therapy and a Division leader since 1999. During this period, he expanded his responsibilities to develop a career in stem cell transplantation in sickle cell disease. The integration of these areas of expertise has enabled him to develop a national program focusing on novel therapies for blood disorders.
Since joining Children’s Hospital, he has devoted his research career to pursuing curative therapies for hemoglobin disorders with an overarching goal of expanding this treatment more broadly to affected individuals. With NIH and industry support, he has conducted a number of multicenter clinical trials for sickle cell disease and thalassemia.
Currently, he is focused on initiating early phase clinical trials to test novel genomic editing techniques in hematopoietic stem cells (HCT) from individuals affected by hemoglobin disorders, starting with a high-profile trial in sickle cell disease. Other projects in the pipeline include activation of fetal hemoglobin by genomic editing in stem cells.
+myBinderRelated Content
-
Practice variation in emergency department management of children with sickle cell disease who present with feverOBJECTIVES:Urgent medical evaluation is ...
-
The Sickle Cell Care Coordination InitiativeThe Sickle Cell Care Coordination Initia...
-
Today’s Faces of Sickle Cell Disease: Tosin OlaDuring a long hospitalization in 2005, T...
-
PCORI Board Approves $18 Million for Research on Sickle Cell DiseaseThe Patient-Centered Outcomes Research I...
-
Sophie Lanzkron, MD, MHSDr. Sophie Lanzkron is an associate prof...
-
Sancilio Pharmaceuticals Company, Inc. Announces Completion of Enrollment in the SCOT Trial in Pediatric Patients Wi...Sancilio Pharmaceuticals Company, Inc. (...
-
Data Brief: Healthcare Utilization for Vaso-Occlusive Episodes by People with Sickle Cell Disease in California and ...Many people with sickle cell disease (SC...
